Calithera Biosciences, Inc. Gains 37.5%
Wed, Mar 29, 2023 at 07:03 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) jumped higher at $0.06, representing a gain of 37.5%. From Wed, Mar 15, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Troika Media Group Inc. (TRKA:NASDAQ), 49.5%
- Local Bounti Corporation (LOCL:NYSE), 46.86%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 42.33%
- LogicMark Inc Com Par$ (New) (LGMK:NASDAQ), 39.29%
- Nexters Inc. (GDEV:NASDAQ), 38.35%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 37.5%
- CBL International Limited (BANL:NASDAQ), 35.24%
- E-Home Household Service Holdings Limited (EJH:NASDAQ), 34.45%
- Tempest Therapeutics Inc. (TPST:NASDAQ), 33.71%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 32.61%